Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 24.10.2024
QUANTRO Therapeutics GmbH
QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
Strategic partnership with the Research Institute of Molecular Pathology (IMP) to decipher transcription factor complexes
QUANTRO CEO Dr. Michael Bauer to attend BIO-Europe in Stockholm, November 4-6
Vienna, Austria, 24 October 2024: QUANTRO [ … ]
Thu, 24.10.2024
Zentiva AG
APONTIS PHARMA shareholders can tender their shares from today – Offer Document published
Voluntary public purchase offer for APONTIS PHARMA starts today – Offer Document published
Acceptance period expected to expire on 21 November 2024 at 24:00 (CET)
Offer price of EUR 10.00 in cash represents a premium of 52.9% over the closing share pri [ … ]
Thu, 24.10.2024
Cherry SE
Munich, 24 October 2024 - Cherry SE today announces preliminary financial performance indicators for the third quarter and the first nine months of 2024. Key aspects of the recently updated forecast for the 2024 financial year are also explained. Both the high proportion of business in Germany and the structural problems in the Gaming & Office [ … ]
Thu, 24.10.2024
LPKF Laser & Electronics SE
Megatrend AI and transformation in the semiconductor market drive strong demand for LIDE products
Ongoing reluctance to invest in the automotive market leads to slight adjustment of guidance for the full year
Concrete measures to reduce fixed costs and optimize overall efficiency have been identified and are being implemented
Garbsen, 24 October [ … ]
Thu, 24.10.2024
Villeroy & Boch AG
Press Release
Mettlach, 24 October 2024
Interim report for the third quarter of 2024
Villeroy & Boch achieves consolidated revenue in excess of € 1 billion for the first time
Consolidated revenue of € 1,007.8 million (previous year: € 650.6 million) exceeds € 1 billion for the first time
Operating EBIT up 11.6 % year-on-year at € 64.5 m [ … ]
Thu, 24.10.2024
Rentschler Biopharma SE
Rentschler Biopharma announces largest single investment at its headquarters in Germany
Construction of a new buffer media facility in Laupheim
Largest investment in the German site; project duration of approx. three years
Continuous modernization, automation, and digitalization of the site
Laupheim, Germany, October 24, 2024 – Rentschler Bioph [ … ]
Thu, 24.10.2024
TAKKT AG
TAKKT records improved sales and earnings development in the third quarter and focuses on long-term success
Sales and earnings in the third quarter significantly better than in the previous quarter
Positive contributions to the improvement from non-recurring effects
Measures to resolve internal challenges prove effective, but business developm [ … ]
Thu, 24.10.2024
Symrise AG
Trading Statement 9M 2024Holzminden, 24 October 2024
Symrise continues strong profitable growth course
Group sales up 11.1% (organic) to €3,824 million in the first nine months, up 10.2% in the third quarter
Both segments, Taste, Nutrition & Health and Scent & Care, achieved double digit growth
Organic sales target expected to [ … ]
Thu, 24.10.2024
Siltronic AG
Press release
Siltronic AG
Einsteinstrasse 172
81677 Munichwww.siltronic.com
Siltronic closes Q3 2024 in line with expectations
- Sales in the first nine months of 2024 declined 9.1 percent compared to the previous year; Q3 increased 1.7 percent q-o-q to EUR 357.3 million
- EBITDA margin remains solid at 25.7 percent after nine months (Q3 2 [ … ]
Thu, 24.10.2024
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Outlook 2024 confirmed: Flat year-on-year sales in CER and a CORE EBITDA margin of high 20s
Strong commercial and operational performance across the CDMO business in Q3; demand remains soft in Capsules & Health Ingredients and Bioscience businesses
Successful completion of the acquisition o [ … ]